{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:24:07Z","timestamp":1792157047360,"version":"4.4.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011699","name":"BRACE","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/Y014685\/1"],"award-info":[{"award-number":["MR\/Y014685\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Huntington\u2019s disease is caused by a trinucleotide CAG repeat expansion in the\n                      <jats:italic>HTT<\/jats:italic>\n                      gene. Despite displaying autosomal dominance, phenotypic variation exists amongst mutation carriers, in particular relating to the age that symptoms first occur. This variation is primarily driven by an inverse relationship between CAG expansion size and age of symptom onset. However, the majority of variation in age of onset that is independent of CAG repeat length is thought to be driven by environmental influences. Since DNA methylation can be altered by environmental factors, and as methylomic variation is reported in other neurodegenerative diseases, it may offer a potential mechanism underlying disease manifestation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We utilized the Illumina EPIC v1 methylation array to profile DNA methylation in 120 samples, including three distinct brain regions (striatum, entorhinal cortex and cerebellum) in 20 Huntington\u2019s disease and 22 control donors. We identified seven Bonferroni-significant differentially methylated CpGs within the striatum along with 27 differentially methylated regions, annotated to genes involved in physiological processes known to be disrupted in HD such as the urea cycle and metabolism. Weighted gene correlation network analysis identified modules of co-methylated CpGs that were associated with Huntington\u2019s disease, with ontological analyses showing enrichment in disease relevant processes. Furthermore, integration of single-nuclei RNA sequencing data highlighted that genes annotated to these modules are enriched in striatal spiny projection neurons, the primary cell types affected in the disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Here, we present the first epigenome-wide association study of Huntington\u2019s disease conducted in the striatum, the primary region of neuropathology, along with matched entorhinal cortex and cerebellum on the Illumina EPIC v1 array. Our results suggest that DNA methylation is altered at loci associated with Huntington\u2019s disease in disease relevant regions and cell types and strengthens evidence for areas of potential therapeutic intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13148-026-02082-4","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T22:36:33Z","timestamp":1779748593000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["DNA methylation profiling in Huntington\u2019s disease reveals disease associated changes in the striatum"],"prefix":"10.1186","volume":"18","author":[{"given":"Gregory","family":"Wheildon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Weymouth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Kouhsar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lachlan F.","family":"MacBean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Troakes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Pishva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca G.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Lunnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"issue":"6","key":"2082_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME MacDonald","year":"1993","unstructured":"MacDonald ME, Ambrose CM, Duyao MP, Myers RH, Lin C, Srinidhi L, et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell. 1993;72(6):971\u201383.","journal-title":"Cell"},{"key":"2082_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c3109","author":"MJ Novak","year":"2010","unstructured":"Novak MJ, Tabrizi SJ. Huntington\u2019s disease. BMJ. 2010. https:\/\/doi.org\/10.1136\/bmj.c3109.","journal-title":"BMJ"},{"issue":"14","key":"2082_CR3","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.1002\/hbm.24695","volume":"40","author":"GR Poudel","year":"2019","unstructured":"Poudel GR, Harding IH, Egan GF, Georgiou\u2010Karistianis N. Network spread determines severity of degeneration and disconnection in Huntington\u2019s disease. Hum Brain Mapp. 2019;40(14):4192\u2013201.","journal-title":"Hum Brain Mapp"},{"issue":"4","key":"2082_CR4","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/ana.410310412","volume":"31","author":"RL Albin","year":"1992","unstructured":"Albin RL, Reiner A, Anderson KD, Dure LS IV, Handelin B, Balfour R, et al. Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington\u2019s disease. Ann Neurol. 1992;31(4):425\u201330.","journal-title":"Ann Neurol"},{"issue":"4","key":"2082_CR5","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1093\/brain\/awn025","volume":"131","author":"HD Rosas","year":"2008","unstructured":"Rosas HD, Salat DH, Lee SY, Zaleta AK, Pappu V, Fischl B, et al. Cerebral cortex and the clinical expression of Huntington\u2019s disease: complexity and heterogeneity. Brain. 2008;131(4):1057\u201368.","journal-title":"Brain"},{"issue":"6","key":"2082_CR6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1365-2990.1992.tb00824.x","volume":"18","author":"H Braak","year":"1992","unstructured":"Braak H, Braak E. Allocortical involvement in Huntington\u2019s disease. Neuropathol Appl Neurobiol. 1992;18(6):539\u201347.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"3","key":"2082_CR7","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/ana.25413","volume":"85","author":"MK Singh\u2010Bains","year":"2019","unstructured":"Singh\u2010Bains MK, Mehrabi NF, Sehji T, Austria MD, Tan AY, Tippett LJ, et al. Cerebellar degeneration correlates with motor symptoms in Huntington disease. Ann Neurol. 2019;85(3):396\u2013405.","journal-title":"Ann Neurol"},{"issue":"1","key":"2082_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","volume":"10","author":"SJ Tabrizi","year":"2011","unstructured":"Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R, et al. Biological and clinical changes in premanifest and early stage Huntington\u2019s disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol. 2011;10(1):31\u201342.","journal-title":"Lancet Neurol"},{"issue":"4","key":"2082_CR9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/ng0893-387","volume":"4","author":"M Duyao","year":"1993","unstructured":"Duyao M, Ambrose C, Myers R, Novelletto A, Persichetti F, Frontali M, et al. Trinucleotide repeat length instability and age of onset in Huntington\u2019s disease. Nat Genet. 1993;4(4):387\u201392.","journal-title":"Nat Genet"},{"issue":"4","key":"2082_CR10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1399-0004.2004.00241.x","volume":"65","author":"DR Langbehn","year":"2004","unstructured":"Langbehn DR, Brinkman RR, Falush D, Paulsen JS, Hayden M, Group aIHsDC. A new model for prediction of the age of onset and penetrance for Huntington\u2019s disease based on CAG length. Clin Genet. 2004;65(4):267\u201377.","journal-title":"Clin Genet"},{"issue":"10","key":"2082_CR11","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1073\/pnas.0308679101","volume":"101","author":"NS Wexler","year":"2004","unstructured":"Project* UVCR, Wexler NS. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington\u2019s disease age of onset. Proc Natl Acad Sci U S A. 2004;101(10):3498\u2013503.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2082_CR12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ajhg.2015.12.018","volume":"98","author":"JW Keum","year":"2016","unstructured":"Keum JW, Shin A, Gillis T, Mysore JS, Elneel KA, Lucente D, et al. The HTT CAG-expansion mutation determines age at death but not disease duration in Huntington disease. Am J Hum Genet. 2016;98(2):287\u201398.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"2082_CR13","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cell.2015.07.003","volume":"162","author":"J-M Lee","year":"2015","unstructured":"Lee J-M, Wheeler VC, Chao MJ, Vonsattel JPG, Pinto RM, Lucente D, et al. Identification of genetic factors that modify clinical onset of Huntington\u2019s disease. Cell. 2015;162(3):516\u201326.","journal-title":"Cell"},{"issue":"7","key":"2082_CR14","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1093\/brain\/awz115","volume":"142","author":"M Flower","year":"2019","unstructured":"Flower M, Lomeikaite V, Ciosi M, Cumming S, Morales F, Lo K, et al. MSH3 modifies somatic instability and disease severity in Huntington\u2019s and myotonic dystrophy type 1. Brain. 2019;142(7):1876\u201386.","journal-title":"Brain"},{"issue":"4","key":"2082_CR15","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.cell.2019.06.036","volume":"178","author":"J-M Lee","year":"2019","unstructured":"Lee J-M, Correia K, Loupe J, Kim K-H, Barker D, Hong EP, et al. CAG repeat not polyglutamine length determines timing of Huntington\u2019s disease onset. Cell. 2019;178(4):887-900.e14.","journal-title":"Cell"},{"issue":"2","key":"2082_CR16","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/jnc.14148","volume":"143","author":"JAY Roubroeks","year":"2017","unstructured":"Roubroeks JAY, Smith RG, van den Hove DLA, Lunnon K. Epigenetics and DNA methylomic profiling in Alzheimer\u2019s disease and other neurodegenerative diseases. J Neurochem. 2017;143(2):158\u201370.","journal-title":"J Neurochem"},{"issue":"7","key":"2082_CR17","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/nan.12650","volume":"46","author":"AR Smith","year":"2020","unstructured":"Smith AR, Wheildon G, Lunnon K. Invited review\u2013a 5\u2010year update on epigenome\u2010wide association studies of DNA modifications in Alzheimer\u2019s disease: progress, practicalities and promise. Neuropathol Appl Neurobiol. 2020;46(7):641\u201353.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2082_CR18","doi-asserted-by":"crossref","unstructured":"Weymouth L, Smith AR, Lunnon K. DNA methylation in Alzheimer\u2019s disease. 2024.","DOI":"10.1007\/7854_2024_530"},{"key":"2082_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s40142-020-00190-y","volume":"8","author":"LF MacBean","year":"2020","unstructured":"MacBean LF, Smith AR, Lunnon K. Exploring beyond the DNA sequence: a review of epigenomic studies of DNA and histone modifications in dementia. Curr Genet Med Rep. 2020;8:79\u201392.","journal-title":"Curr Genet Med Rep"},{"key":"2082_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106337","volume":"188","author":"J Harvey","year":"2023","unstructured":"Harvey J, Pishva E, Chouliaras L, Lunnon K. Elucidating distinct molecular signatures of Lewy body dementias. Neurobiol Dis. 2023;188:106337.","journal-title":"Neurobiol Dis"},{"key":"2082_CR21","doi-asserted-by":"crossref","unstructured":"Harvey J, Imm J, Kouhsar M, Smith AR, Creese B, Smith RG, et al. Interrogating DNA methylation associated with Lewy body pathology in a cross brain-region and multi-cohort study. medRxiv. 2025","DOI":"10.1101\/2025.03.13.25323837"},{"issue":"6","key":"2082_CR22","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1073\/pnas.1221292110","volume":"110","author":"CW Ng","year":"2013","unstructured":"Ng CW, Yildirim F, Yap YS, Dalin S, Matthews BJ, Velez PJ, et al. Extensive changes in DNA methylation are associated with expression of mutant huntingtin. Proc Natl Acad Sci. 2013;110(6):2354\u20139.","journal-title":"Proc Natl Acad Sci"},{"issue":"7","key":"2082_CR23","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.18632\/aging.101005","volume":"8","author":"S Horvath","year":"2016","unstructured":"Horvath S, Langfelder P, Kwak S, Aaronson J, Rosinski J, Vogt TF, et al. Huntington\u2019s disease accelerates epigenetic aging of human brain and disrupts DNA methylation levels. Aging. 2016;8(7):1485.","journal-title":"Aging"},{"issue":"10","key":"2082_CR24","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1093\/hmg\/ddw076","volume":"25","author":"RA De Souza","year":"2016","unstructured":"De Souza RA, Islam SA, McEwen LM, Mathelier A, Hill A, Mah SM, et al. DNA methylation profiling in human Huntington\u2019s disease brain. Hum Mol Genet. 2016;25(10):2013\u201330.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"2082_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-18255-5","volume":"11","author":"AT Lu","year":"2020","unstructured":"Lu AT, Narayan P, Grant MJ, Langfelder P, Wang N, Kwak S, et al. DNA methylation study of Huntington\u2019s disease and motor progression in patients and in animal models. Nat Commun. 2020;11(1):1\u201315.","journal-title":"Nat Commun"},{"key":"2082_CR26","doi-asserted-by":"crossref","unstructured":"Pircs K, Drouin-Ouellet J, Gil J, Rezeli M, Grassi DA, Garza R, et al. Distinct sub-cellular autophagy impairments occur independently of protein aggregation in induced neurons from patients with Huntington\u2019s disease. bioRxiv. 2021.","DOI":"10.1101\/2021.03.01.433433"},{"key":"2082_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neurobiolaging.2018.09.024","volume":"74","author":"AR Smith","year":"2019","unstructured":"Smith AR, Smith RG, Burrage J, Troakes C, Al-Sarraj S, Kalaria RN, et al. A cross-brain regions study of ANK1 DNA methylation in different neurodegenerative diseases. Neurobiol Aging. 2019;74:70\u20136.","journal-title":"Neurobiol Aging"},{"key":"2082_CR28","unstructured":"Team RC. R: A language and environment for statistical computing: R Foundation for Statistical Computing, Vienna, 2018."},{"issue":"10","key":"2082_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2004-5-10-r80","volume":"5","author":"RC Gentleman","year":"2004","unstructured":"Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5(10):R80.","journal-title":"Genome Biol"},{"key":"2082_CR30","unstructured":"Davis S, Du P, Bilke S, Triche T, Bootwalla M. methylumi: Handle Illumina methylation data. R package version. 2015;2."},{"issue":"10","key":"2082_CR31","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","volume":"30","author":"MJ Aryee","year":"2014","unstructured":"Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014;30(10):1363\u20139.","journal-title":"Bioinformatics"},{"issue":"1","key":"2082_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2164-14-293","volume":"14","author":"R Pidsley","year":"2013","unstructured":"Pidsley R, Y Wong CC, Volta M, Lunnon K, Mill J, Schalkwyk LC. A data-driven approach to preprocessing Illumina 450K methylation array data. BMC Genomics. 2013;14(1):1\u201310.","journal-title":"BMC Genomics"},{"key":"2082_CR33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.gdata.2016.05.012","volume":"9","author":"DL McCartney","year":"2016","unstructured":"McCartney DL, Walker RM, Morris SW, McIntosh AM, Porteous DJ, Evans KL. Identification of polymorphic and off-target probe binding sites on the Illumina Infinium MethylationEPIC BeadChip. Genom Data. 2016;9:22\u20134.","journal-title":"Genom Data"},{"issue":"3","key":"2082_CR34","doi-asserted-by":"publisher","first-page":"290","DOI":"10.4161\/epi.23924","volume":"8","author":"J Guintivano","year":"2013","unstructured":"Guintivano J, Aryee MJ, Kaminsky ZA. A cell epigenotype specific model for the correction of brain cellular heterogeneity bias and its application to age, brain region and major depression. Epigenetics. 2013;8(3):290\u2013302.","journal-title":"Epigenetics"},{"issue":"2 (25)","key":"2082_CR35","doi-asserted-by":"publisher","first-page":"42","DOI":"10.32607\/20758251-2015-7-2-42-47","volume":"7","author":"V Gusel'Nikova","year":"2015","unstructured":"Gusel\u2019Nikova V, Korzhevskiy D. NeuN as a neuronal nuclear antigen and neuron differentiation marker. Acta Naturae (a\u043d\u0433\u043bo\u044f\u0437\u044b\u0447\u043da\u044f \u0432epc\u0438\u044f). 2015;7(2 (25)):42\u20137.","journal-title":"Acta Naturae (a\u043d\u0433\u043bo\u044f\u0437\u044b\u0447\u043da\u044f \u0432epc\u0438\u044f)"},{"issue":"1","key":"2082_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13059-016-1131-9","volume":"18","author":"M van Iterson","year":"2017","unstructured":"van Iterson M, van Zwet EW, Heijmans BT. Controlling bias and inflation in epigenome- and transcriptome-wide association studies using the empirical null distribution. Genome Biol. 2017;18(1):19.","journal-title":"Genome Biol"},{"issue":"9","key":"2082_CR37","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/nn.3782","volume":"17","author":"K Lunnon","year":"2014","unstructured":"Lunnon K, Smith R, Hannon E, De Jager PL, Srivastava G, Volta M, et al. Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer\u2019s disease. Nat Neurosci. 2014;17(9):1164\u201370.","journal-title":"Nat Neurosci"},{"issue":"1","key":"2082_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33394-7","volume":"13","author":"G Shireby","year":"2022","unstructured":"Shireby G, Dempster EL, Policicchio S, Smith RG, Pishva E, Chioza B, et al. DNA methylation signatures of Alzheimer\u2019s disease neuropathology in the cortex are primarily driven by variation in non-neuronal cell-types. Nat Commun. 2022;13(1):5620.","journal-title":"Nat Commun"},{"issue":"1","key":"2082_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-23243-4","volume":"12","author":"RG Smith","year":"2021","unstructured":"Smith RG, Pishva E, Shireby G, Smith AR, Roubroeks JA, Hannon E, et al. A meta-analysis of epigenome-wide association studies in Alzheimer\u2019s disease highlights novel differentially methylated loci across cortex. Nat Commun. 2021;12(1):1\u201313.","journal-title":"Nat Commun"},{"issue":"22","key":"2082_CR40","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1093\/bioinformatics\/bts545","volume":"28","author":"BS Pedersen","year":"2012","unstructured":"Pedersen BS, Schwartz DA, Yang IV, Kechris KJ. Comb-p: software for combining, analyzing, grouping and correcting spatially correlated P-values. Bioinformatics. 2012;28(22):2986\u20138.","journal-title":"Bioinformatics"},{"issue":"4","key":"2082_CR41","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez C, K\u00fc\u00e7\u00fckali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet. 2022;54(4):412\u201336.","journal-title":"Nat Genet"},{"issue":"1","key":"2082_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008;9(1):559.","journal-title":"BMC Bioinform"},{"issue":"2","key":"2082_CR43","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1093\/bioinformatics\/btv560","volume":"32","author":"B Phipson","year":"2016","unstructured":"Phipson B, Maksimovic J, Oshlack A. missMethyl: an R package for analyzing data from Illumina\u2019s HumanMethylation450 platform. Bioinformatics. 2016;32(2):286\u20138.","journal-title":"Bioinformatics"},{"key":"2082_CR44","unstructured":"Sayols S. rrvgo: a Bioconductor package for interpreting lists of Gene Ontology terms. MicroPubl Biol. 2023;2023."},{"issue":"5","key":"2082_CR45","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.neuron.2020.06.021","volume":"107","author":"H Lee","year":"2020","unstructured":"Lee H, Fenster RJ, Pineda SS, Gibbs WS, Mohammadi S, Davila-Velderrain J, et al. Cell type-specific transcriptomics reveals that mutant Huntingtin leads to mitochondrial RNA release and neuronal innate immune activation. Neuron. 2020;107(5):891-908.e8.","journal-title":"Neuron"},{"key":"2082_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2016.00016","volume":"10","author":"NG Skene","year":"2016","unstructured":"Skene NG, Grant SG. Identification of vulnerable cell types in major brain disorders using single cell transcriptomes and expression weighted cell type enrichment. Front Neurosci. 2016;10:179460.","journal-title":"Front Neurosci"},{"issue":"4","key":"2082_CR47","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4161\/epi.2.4.5380","volume":"2","author":"J Peters","year":"2007","unstructured":"Peters J, Williamson CM. Control of imprinting at the Gnas cluster. Epigenetics. 2007;2(4):207\u201313.","journal-title":"Epigenetics"},{"issue":"1","key":"2082_CR48","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1086\/302712","volume":"66","author":"K Kosaki","year":"2000","unstructured":"Kosaki K, Kosaki R, Craigen WJ, Matsuo N. Isoform-specific imprinting of the human PEG1\/MEST gene. Am J Hum Genet. 2000;66(1):309\u201312.","journal-title":"Am J Hum Genet"},{"issue":"13","key":"2082_CR49","doi-asserted-by":"publisher","first-page":"4320","DOI":"10.1016\/j.celrep.2019.11.096","volume":"29","author":"A M\u00e4rtin","year":"2019","unstructured":"M\u00e4rtin A, Calvigioni D, Tzortzi O, Fuzik J, W\u00e4rnberg E, Meletis K. A spatiomolecular map of the striatum. Cell Rep. 2019;29(13):4320-33. e5.","journal-title":"Cell Rep"},{"key":"2082_CR50","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/B978-0-444-52014-2.00004-5","volume":"100","author":"JPG Vonsattel","year":"2011","unstructured":"Vonsattel JPG, Keller C, Ramirez EPC. Huntington\u2019s disease\u2013neuropathology. Handb Clin Neurol. 2011;100:83\u2013100.","journal-title":"Handb Clin Neurol"},{"issue":"2","key":"2082_CR51","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s12017-013-8219-0","volume":"15","author":"I Villar-Men\u00e9ndez","year":"2013","unstructured":"Villar-Men\u00e9ndez I, Blanch M, Tyebji S, Pereira-Veiga T, Albasanz JL, Mart\u00edn M, et al. Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington\u2019s disease. Neuromol Med. 2013;15(2):295\u2013309.","journal-title":"Neuromol Med"},{"issue":"8","key":"2082_CR52","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1091\/mbc.e15-04-0218","volume":"28","author":"YH Lin","year":"2017","unstructured":"Lin YH, Zhen YY, Chien KY, Lee IC, Lin WC, Chen MY, et al. LIMCH1 regulates nonmuscle myosin-II activity and suppresses cell migration. Mol Biol Cell. 2017;28(8):1054\u201365.","journal-title":"Mol Biol Cell"},{"key":"2082_CR53","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00418-015-1389-0","volume":"145","author":"D Garc\u00eda","year":"2016","unstructured":"Garc\u00eda D, Ordenes P, Ben\u00edtez J, Gonz\u00e1lez A, Garc\u00eda-Robles MA, L\u00f3pez V, et al. Cloning of two LIMCH1 isoforms: characterization of their distribution in rat brain and their agmatinase activity. Histochem Cell Biol. 2016;145:305\u201313.","journal-title":"Histochem Cell Biol"},{"issue":"9","key":"2082_CR54","first-page":"1650","volume":"1862","author":"S Patassini","year":"2016","unstructured":"Patassini S, Begley P, Xu J, Church SJ, Reid SJ, Kim EH, et al. Metabolite mapping reveals severe widespread perturbation of multiple metabolic processes in Huntington\u2019s disease human brain. Biochem Biophys Acta. 2016;1862(9):1650\u201362.","journal-title":"Biochem Biophys Acta"},{"issue":"6","key":"2082_CR55","first-page":"1596","volume":"1863","author":"TJV Bichell","year":"2017","unstructured":"Bichell TJV, Wegrzynowicz M, Tipps KG, Bradley EM, Uhouse MA, Bryan M, et al. Reduced bioavailable manganese causes striatal urea cycle pathology in Huntington\u2019s disease mouse model. Biochem Biophys Acta. 2017;1863(6):1596\u2013604.","journal-title":"Biochem Biophys Acta"},{"issue":"1","key":"2082_CR56","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.devcel.2011.10.025","volume":"22","author":"K Lee Hyun","year":"2012","unstructured":"Lee Hyun K, Deneen B. Daam2 is required for dorsal patterning via modulation of canonical Wnt signaling in the developing spinal cord. Dev Cell. 2012;22(1):183\u201396.","journal-title":"Dev Cell"},{"issue":"13","key":"2082_CR57","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1093\/hmg\/ddi192","volume":"14","author":"AD Strand","year":"2005","unstructured":"Strand AD, Aragaki AK, Shaw D, Bird T, Holton J, Turner C, et al. Gene expression in Huntington\u2019s disease skeletal muscle: a potential biomarker. Hum Mol Genet. 2005;14(13):1863\u201376.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"2082_CR58","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.neuroscience.2009.01.022","volume":"159","author":"T Nishimura","year":"2009","unstructured":"Nishimura T, Kubosaki A, Ito Y, Notkins AL. Disturbances in the secretion of neurotransmitters in IA-2\/IA-2\u03b2 null mice: changes in behavior, learning and lifespan. Neuroscience. 2009;159(2):427\u201337.","journal-title":"Neuroscience"},{"issue":"1","key":"2082_CR59","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.mce.2009.09.023","volume":"315","author":"T Nishimura","year":"2010","unstructured":"Nishimura T, Harashima S-i, Yafang H, Notkins AL. IA-2 modulates dopamine secretion in PC12 cells. Mol Cell Endocrinol. 2010;315(1):81\u20136.","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"2082_CR60","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.stem.2012.04.027","volume":"11","author":"The Hd iPsc Consortium","year":"2012","unstructured":"The Hd iPsc Consortium. Induced pluripotent stem cells from patients with Huntington\u2019s disease Show CAG-repeat-expansion-associated phenotypes. Cell Stem Cell. 2012;11(2):264\u201378.","journal-title":"Cell Stem Cell"},{"issue":"7","key":"2082_CR61","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/j.celrep.2018.04.052","volume":"23","author":"NH Skotte","year":"2018","unstructured":"Skotte NH, Andersen JV, Santos A, Aldana BI, Willert CW, N\u00f8rrem\u00f8lle A, et al. Integrative characterization of the R6\/2 mouse model of Huntington\u2019s disease reveals dysfunctional astrocyte metabolism. Cell Rep. 2018;23(7):2211\u201324.","journal-title":"Cell Rep"},{"issue":"2","key":"2082_CR62","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1042\/BJ20120324","volume":"446","author":"S Kume","year":"2012","unstructured":"Kume S, Lee Y-H, Miyamoto Y, Fukada H, Goto Y, Inui T. Systematic interaction analysis of human lipocalin-type prostaglandin D synthase with small lipophilic ligands. Biochem J. 2012;446(2):279\u201389.","journal-title":"Biochem J"},{"issue":"1","key":"2082_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35388-x","volume":"13","author":"RG Lim","year":"2022","unstructured":"Lim RG, Al-Dalahmah O, Wu J, Gold MP, Reidling JC, Tang G, et al. Huntington disease oligodendrocyte maturation deficits revealed by single-nucleus RNAseq are rescued by thiamine-biotin supplementation. Nat Commun. 2022;13(1):7791.","journal-title":"Nat Commun"},{"issue":"15","key":"2082_CR64","doi-asserted-by":"publisher","first-page":"6412","DOI":"10.1073\/pnas.0701585104","volume":"104","author":"T Kanekiyo","year":"2007","unstructured":"Kanekiyo T, Ban T, Aritake K, Huang Z-L, Qu W-M, Okazaki I, et al. Lipocalin-type prostaglandin D synthase\/\u03b2-trace is a major amyloid \u03b2-chaperone in human cerebrospinal fluid. Proc Natl Acad Sci. 2007;104(15):6412\u20137.","journal-title":"Proc Natl Acad Sci"},{"issue":"52","key":"2082_CR65","doi-asserted-by":"publisher","first-page":"E11293","DOI":"10.1073\/pnas.1711243115","volume":"114","author":"RR Handley","year":"2017","unstructured":"Handley RR, Reid SJ, Brauning R, Maclean P, Mears ER, Fourie I, et al. Brain urea increase is an early Huntington\u2019s disease pathogenic event observed in a prodromal transgenic sheep model and HD cases. Proc Natl Acad Sci USA. 2017;114(52):E11293\u2013302.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2082_CR66","unstructured":"Consortium GMoHsD, Lee J-M, McLean ZL, Correia K, Shin JW, Lee S, et al. Genetic modifiers of somatic expansion and clinical phenotypes in Huntington's disease reveal shared and tissue-specific effects. bioRxiv. 2024:2024.06. 10.597797."},{"issue":"9","key":"2082_CR67","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U V\u00f5sa","year":"2021","unstructured":"V\u00f5sa U, Claringbould A, Westra H-J, Bonder MJ, Deelen P, Zeng B, et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet. 2021;53(9):1300\u201310.","journal-title":"Nat Genet"},{"issue":"1","key":"2082_CR68","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s41467-020-20605-2","volume":"12","author":"R Alcal\u00e1-Vida","year":"2021","unstructured":"Alcal\u00e1-Vida R, Seguin J, Lotz C, Molitor AM, Irastorza-Azcarate I, Awada A, et al. Age-related and disease locus-specific mechanisms contribute to early remodelling of chromatin structure in Huntington\u2019s disease mice. Nat Commun. 2021;12(1):364.","journal-title":"Nat Commun"},{"issue":"5","key":"2082_CR69","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.ajhg.2022.03.004","volume":"109","author":"J-M Lee","year":"2022","unstructured":"Lee J-M, Huang Y, Orth M, Gillis T, Siciliano J, Hong E, et al. Genetic modifiers of Huntington disease differentially influence motor and cognitive domains. Am J Hum Genet. 2022;109(5):885\u201399.","journal-title":"Am J Hum Genet"},{"issue":"6","key":"2082_CR70","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/ng1362","volume":"36","author":"B Ravikumar","year":"2004","unstructured":"Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, Oroz LG, et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet. 2004;36(6):585\u201395.","journal-title":"Nat Genet"},{"issue":"1","key":"2082_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43627-3","volume":"9","author":"J Pido-Lopez","year":"2019","unstructured":"Pido-Lopez J, Tanudjojo B, Farag S, Bondulich M-K, Andre R, Tabrizi SJ, et al. Inhibition of tumour necrosis factor alpha in the R6\/2 mouse model of Huntington\u2019s disease by etanercept treatment. Sci Rep. 2019;9(1):7202.","journal-title":"Sci Rep"},{"issue":"6","key":"2082_CR72","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1111\/j.1460-9568.2005.04324.x","volume":"22","author":"E Papalexi","year":"2005","unstructured":"Papalexi E, Persson A, Bj\u00f6rkqvist M, Peters\u00e9n \u00c5, Woodman B, Bates GP, et al. Reduction of GnRH and infertility in the R6\/2 mouse model of Huntington\u2019s disease. Eur J Neurosci. 2005;22(6):1541\u20136.","journal-title":"Eur J Neurosci"},{"key":"2082_CR73","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3233\/JHD-220538","volume":"11","author":"S Podvin","year":"2022","unstructured":"Podvin S, Rosenthal SB, Poon W, Wei E, Fisch KM, Hook V. Mutant Huntingtin protein interaction map implicates dysregulation of multiple cellular pathways in neurodegeneration of Huntington\u2019s Disease. J Huntingtons Dis. 2022;11:243\u201367.","journal-title":"J Huntingtons Dis"},{"key":"2082_CR74","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s12035-014-8735-4","volume":"51","author":"L Naia","year":"2015","unstructured":"Naia L, Ferreira IL, Cunha-Oliveira T, Duarte AI, Ribeiro M, Rosenstock TR, et al. Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington\u2019s Disease human lymphoblasts. Mol Neurobiol. 2015;51:331\u201348.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"2082_CR75","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.drugalcdep.2006.06.009","volume":"86","author":"JC Ehret","year":"2007","unstructured":"Ehret JC, Day PS, Wiegand R, Wojcieszek J, Chambers RA. Huntington disease as a dual diagnosis disorder: data from the national research roster for Huntington disease patients and families. Drug Alcohol Depend. 2007;86(2):283\u20136.","journal-title":"Drug Alcohol Depend"},{"key":"2082_CR76","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1007\/s00415-012-6415-8","volume":"259","author":"JA Byars","year":"2012","unstructured":"Byars JA, Beglinger LJ, Moser DJ, Gonzalez-Alegre P, Nopoulos P. Substance abuse may be a risk factor for earlier onset of Huntington disease. J Neurol. 2012;259:1824\u201331.","journal-title":"J Neurol"},{"issue":"9","key":"2082_CR77","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1212\/WNL.0000000000003661","volume":"88","author":"JL Schultz","year":"2017","unstructured":"Schultz JL, Kamholz JA, Moser DJ, Feely SME, Paulsen JS, Nopoulos PC. Substance abuse may hasten motor onset of Huntington disease. Neurology. 2017;88(9):909\u201315.","journal-title":"Neurology"},{"issue":"2","key":"2082_CR78","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41593-024-01834-w","volume":"28","author":"LE Duncan","year":"2025","unstructured":"Duncan LE, Li T, Salem M, Li W, Mortazavi L, Senturk H, et al. Mapping the cellular etiology of schizophrenia and complex brain phenotypes. Nat Neurosci. 2025;28(2):248\u201358.","journal-title":"Nat Neurosci"},{"issue":"5","key":"2082_CR79","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.celrep.2019.09.059","volume":"29","author":"ME Bocarsly","year":"2019","unstructured":"Bocarsly ME, da Silva e Silva D, Kolb V, Luderman KD, Shashikiran S, Rubinstein M, et al. A Mechanism linking two known vulnerability factors for alcohol abuse: heightened alcohol stimulation and low striatal dopamine D2 receptors. Cell Rep. 2019;29(5):1147\u201363.","journal-title":"Cell Rep"},{"issue":"5","key":"2082_CR80","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/j.1471-4159.2010.06672.x","volume":"113","author":"I Han","year":"2010","unstructured":"Han I, You Y, Kordower JH, Brady ST, Morfini GA. Differential vulnerability of neurons in Huntington\u2019s disease: the role of cell type-specific features. J Neurochem. 2010;113(5):1073\u201391.","journal-title":"J Neurochem"},{"issue":"8","key":"2082_CR81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.0030135","volume":"3","author":"J-M Lee","year":"2007","unstructured":"Lee J-M, Ivanova EV, Seong IS, Cashorali T, Kohane I, Gusella JF, et al. Unbiased gene expression analysis implicates the huntingtin polyglutamine tract in extra-mitochondrial energy metabolism. PLoS Genet. 2007;3(8):e135.","journal-title":"PLoS Genet"},{"issue":"suppl_1","key":"2082_CR82","doi-asserted-by":"publisher","first-page":"R139","DOI":"10.1093\/hmg\/ddi100","volume":"14","author":"CL Ulrey","year":"2005","unstructured":"Ulrey CL, Liu L, Andrews LG, Tollefsbol TO. The impact of metabolism on DNA methylation. Hum Mol Genet. 2005;14(suppl_1):R139\u201347.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"2082_CR83","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.biopsych.2017.10.019","volume":"83","author":"P McColgan","year":"2018","unstructured":"McColgan P, Gregory S, Seunarine KK, Razi A, Papoutsi M, Johnson E, et al. Brain regions showing white matter loss in Huntington\u2019s disease are enriched for synaptic and metabolic genes. Biol Psychiatry. 2018;83(5):456\u201365.","journal-title":"Biol Psychiatry"},{"key":"2082_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2023.102448","volume":"225","author":"J Lange","year":"2023","unstructured":"Lange J, Gillham O, Flower M, Ging H, Eaton S, Kapadia S, et al. PolyQ length-dependent metabolic alterations and DNA damage drive human astrocyte dysfunction in Huntington\u2019s disease. Prog Neurobiol. 2023;225:102448.","journal-title":"Prog Neurobiol"},{"issue":"25","key":"2082_CR85","doi-asserted-by":"publisher","first-page":"5534","DOI":"10.1523\/JNEUROSCI.2074-20.2021","volume":"41","author":"S Malaiya","year":"2021","unstructured":"Malaiya S, Cortes-Gutierrez M, Herb BR, Coffey SR, Legg SR, Cantle JP, et al. Single-nucleus RNA-seq reveals dysregulation of striatal cell identity due to huntington\u2019s disease mutations. J Neurosci. 2021;41(25):5534\u201352.","journal-title":"J Neurosci"},{"key":"2082_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2016.00566","volume":"10","author":"K Reemst","year":"2016","unstructured":"Reemst K, Noctor SC, Lucassen PJ, Hol EM. The indispensable roles of microglia and astrocytes during brain development. Front Hum Neurosci. 2016;10:566.","journal-title":"Front Hum Neurosci"},{"issue":"5","key":"2082_CR87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127222","volume":"10","author":"D Sakry","year":"2015","unstructured":"Sakry D, Yigit H, Dimou L, Trotter J. Oligodendrocyte precursor cells synthesize neuromodulatory factors. PLoS ONE. 2015;10(5):e0127222.","journal-title":"PLoS ONE"},{"issue":"19","key":"2082_CR88","doi-asserted-by":"publisher","first-page":"9622","DOI":"10.1073\/pnas.1818042116","volume":"116","author":"C Ferrari Bardile","year":"2019","unstructured":"Ferrari Bardile C, Garcia-Miralles M, Caron NS, Rayan NA, Langley SR, Harmston N, et al. Intrinsic mutant HTT-mediated defects in oligodendroglia cause myelination deficits and behavioral abnormalities in Huntington disease. Proc Natl Acad Sci USA. 2019;116(19):9622\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2082_CR89","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1365-2990.2005.00690.x","volume":"32","author":"K Kagitani-Shimono","year":"2006","unstructured":"Kagitani-Shimono K, Mohri I, Oda H, Ozono K, Suzuki K, Urade Y, et al. Lipocalin-type prostaglandin D synthase (\u03b2-trace) is upregulated in the \u03b1B-crystallin-positive oligodendrocytes and astrocytes in the chronic multiple sclerosis. Neuropathol Appl Neurobiol. 2006;32(1):64\u201373.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"6","key":"2082_CR90","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"J-P Vonsattel","year":"1985","unstructured":"Vonsattel J-P, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson JEP. Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol. 1985;44(6):559\u201377.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"2082_CR91","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nmeth.4189","volume":"14","author":"AC Rand","year":"2017","unstructured":"Rand AC, Jain M, Eizenga JM, Musselman-Brown A, Olsen HE, Akeson M, et al. Mapping DNA methylation with high-throughput nanopore sequencing. Nat Methods. 2017;14(4):411\u20133.","journal-title":"Nat Methods"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02082-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-026-02082-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02082-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:02:42Z","timestamp":1779753762000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13148-026-02082-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2082"],"URL":"https:\/\/doi.org\/10.1186\/s13148-026-02082-4","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"16 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the study was granted from the University of Exeter Medical School Research Ethics Committee (13\/02\/009).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"92"}}